Mechanism of apoptosis induced by SR1078 activating RORα in ovarian cancer cells
10.16438/j.0513-4870.2017-0814
- VernacularTitle:SR1078激活RORα诱导卵巢癌细胞凋亡的机制研究
- Author:
Lin CHENG
1
;
Yu HOU
1
;
Wei-zhang WANG
1
Author Information
1. School of Basic Courses, Guangdong Pharmaceutical University, Guangzhou 510006, China
- Publication Type:ORIGINAL ARTICLES
- Keywords:
retinoid acid receptor related orphan receptor α;
N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypro-pan-2-yl)phenyl]-4-(trifluoromethyl)benzamide;
ovarian neoplasms;
p53;
apoptosis
- From:
Acta Pharmaceutica Sinica
2018;53(1):62-67
- CountryChina
- Language:Chinese
-
Abstract:
This study was to investigate the effect of RORα activator SR1078 on ovarian cancer cells and its molecular mechanism in vitro. The survival rate of HeyA8 and Hey cells was detected by MTS assay; the apoptosis and cells cycle distribution after SR1078 treatment and the effect of p53 siRNA or PFT-α and PFT-β of p53 inhibitors on SR1078-induced apoptosis of HeyA8 or Hey cells were analyzed by flow cytometry. Western blot was used to detect the effect of SR1078 and p53 siRNA on the expression of p53 protein and the effect of p53 inhibitors alone or in combination with SR1078 on the expression of p53, p-p53 and its downstream pro-apoptotic protein Noxa. The results showed that SR1078 significantly reduced the cell viability and induced apoptosis in HeyA8 and Hey cells. In addition, SR1078 up-regulated the protein expression of p53 and Noxa, and p53 suppression led to significant inhibition of SR1078-induced apoptosis and the expression of Noxa in ovarian cancer cells. In summary, SR1078 induced apoptosis of ovarian cancer cells by activation of p53 signaling pathway.
